{"id":"W4362458336","doi":"10.1002/cam4.5862","title":"Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization","year":2023,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Toronto; St. Michael's Hospital; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Queen's University; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Ipilimumab; Medicine; Reimbursement; Population; Cost effectiveness; Cohort; Internal medicine; Clinical trial; Incremental cost-effectiveness ratio; Quality-adjusted life year; Oncology; Pediatrics; Health care; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01753217,0.0001870679,0.001599107,0.0008628639,0.00009699782,0.000006154499,0.0002010786,0.00005848409,0.0005311334],"category_scores_gemma":[0.002579146,0.0002058333,0.0000851339,0.0009965842,0.00007400461,0.0001334336,0.00002596034,0.00008752439,0.00001910115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000522798,"about_ca_system_score_gemma":0.0001575621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005171292,"about_ca_topic_score_gemma":0.003365485,"domain_scores_codex":[0.9951822,0.0005473451,0.003320396,0.0005057928,0.0001714324,0.0002728876],"domain_scores_gemma":[0.99361,0.003251468,0.002299795,0.0005213074,0.000207579,0.0001098748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003185086,0.0002945849,0.9691038,0.004026801,0.0003357871,7.90325e-7,0.002059674,0.009845865,0.00003031417,0.006932179,0.006645119,0.0004065843],"study_design_scores_gemma":[0.006678613,0.0006933807,0.9586824,0.0005065876,0.0001068528,3.110357e-7,0.001792491,0.02443271,0.00006327266,0.002426307,0.004405766,0.0002113146],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848414,0.0009689818,0.004532415,0.002278008,0.000605005,0.005230554,0.0007485183,0.00006829805,0.0007267999],"genre_scores_gemma":[0.9965545,0.00005524809,0.0001773208,0.0004931457,0.0001958245,0.001354216,0.0005957091,0.00004473868,0.0005292927],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01495302,"threshold_uncertainty_score":0.8393638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5293046685244431,"score_gpt":0.5121395733399435,"score_spread":0.0171650951844996,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}